|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2001-7-23
|
|
pubmed:abstractText |
We have recently shown that high-level expression of the multidrug resistance-associated protein (MRP) gene is a powerful independent predictor of poor outcome in neuroblastoma. The clinical implication of these findings is that MRP modulators may prove therapeutically useful.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/ATP-Binding Cassette Transporters,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Infective Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Antimony Potassium Tartrate,
http://linkedlifedata.com/resource/pubmed/chemical/Ciprofloxacin,
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin,
http://linkedlifedata.com/resource/pubmed/chemical/Daunorubicin,
http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin,
http://linkedlifedata.com/resource/pubmed/chemical/Fluoroquinolones,
http://linkedlifedata.com/resource/pubmed/chemical/Multidrug Resistance-Associated...,
http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Vincristine,
http://linkedlifedata.com/resource/pubmed/chemical/difloxacin
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0098-1532
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
36
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
177-80
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11464877-ATP-Binding Cassette Transporters,
pubmed-meshheading:11464877-Adenocarcinoma,
pubmed-meshheading:11464877-Anti-Infective Agents,
pubmed-meshheading:11464877-Antimony Potassium Tartrate,
pubmed-meshheading:11464877-Breast Neoplasms,
pubmed-meshheading:11464877-Ciprofloxacin,
pubmed-meshheading:11464877-Cisplatin,
pubmed-meshheading:11464877-Daunorubicin,
pubmed-meshheading:11464877-Doxorubicin,
pubmed-meshheading:11464877-Drug Evaluation, Preclinical,
pubmed-meshheading:11464877-Drug Resistance, Multiple,
pubmed-meshheading:11464877-Drug Resistance, Neoplasm,
pubmed-meshheading:11464877-Fluoroquinolones,
pubmed-meshheading:11464877-Gene Amplification,
pubmed-meshheading:11464877-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:11464877-Genes, myc,
pubmed-meshheading:11464877-Humans,
pubmed-meshheading:11464877-Multidrug Resistance-Associated Proteins,
pubmed-meshheading:11464877-Neoplasm Proteins,
pubmed-meshheading:11464877-Neuroblastoma,
pubmed-meshheading:11464877-Polymerase Chain Reaction,
pubmed-meshheading:11464877-Substrate Specificity,
pubmed-meshheading:11464877-Tumor Cells, Cultured,
pubmed-meshheading:11464877-Vincristine
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Reversal of multidrug resistance-associated protein-mediated drug resistance in cultured human neuroblastoma cells by the quinolone antibiotic difloxacin.
|
|
pubmed:affiliation |
Children's Cancer Institute Australia for Medical Research, Sydney Children's Hospital.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
